Editorial: Vascular- and immuno-metabolism as drivers of cardiovascular disease: insights obtained from omics approaches
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Cell and Developmental Biology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2025.1559828/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832582907054522368 |
|---|---|
| author | Emiel P. C. van der Vorst Emiel P. C. van der Vorst Emiel P. C. van der Vorst Emiel P. C. van der Vorst Jeffrey Kroon Jeffrey Kroon Jeffrey Kroon Jeffrey Kroon Raquel Guillamat-Prats Raquel Guillamat-Prats Raquel Guillamat-Prats Yvonne Döring Yvonne Döring Yvonne Döring Yvonne Döring |
| author_facet | Emiel P. C. van der Vorst Emiel P. C. van der Vorst Emiel P. C. van der Vorst Emiel P. C. van der Vorst Jeffrey Kroon Jeffrey Kroon Jeffrey Kroon Jeffrey Kroon Raquel Guillamat-Prats Raquel Guillamat-Prats Raquel Guillamat-Prats Yvonne Döring Yvonne Döring Yvonne Döring Yvonne Döring |
| author_sort | Emiel P. C. van der Vorst |
| collection | DOAJ |
| format | Article |
| id | doaj-art-763c8950a4eb44f1bdf2bc4ac418955a |
| institution | Kabale University |
| issn | 2296-634X |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Cell and Developmental Biology |
| spelling | doaj-art-763c8950a4eb44f1bdf2bc4ac418955a2025-01-29T06:45:53ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2025-01-011310.3389/fcell.2025.15598281559828Editorial: Vascular- and immuno-metabolism as drivers of cardiovascular disease: insights obtained from omics approachesEmiel P. C. van der Vorst0Emiel P. C. van der Vorst1Emiel P. C. van der Vorst2Emiel P. C. van der Vorst3Jeffrey Kroon4Jeffrey Kroon5Jeffrey Kroon6Jeffrey Kroon7Raquel Guillamat-Prats8Raquel Guillamat-Prats9Raquel Guillamat-Prats10Yvonne Döring11Yvonne Döring12Yvonne Döring13Yvonne Döring14Department of Internal Medicine I – Cardiology, Uniklinik RWTH Aachen, RWTH Aachen University, Aachen, GermanyInstitute for Molecular Cardiovascular Research (IMCAR), Uniklinik RWTH Aachen, RWTH Aachen University, Aachen, GermanyAachen-Maastricht Institute for Cardio-Renal Disease (AMICARE), Uniklinik RWTH Aachen, RWTH Aachen University, Aachen, GermanyInstitute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-Universität, Munich, GermanyDepartment of Experimental Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC Location University of Amsterdam, Amsterdam, NetherlandsAmsterdam Cardiovascular Sciences, Atherosclerosis and Ischemic Syndromes, Amsterdam, NetherlandsLaboratory of Angiogenesis and Vascular Metabolism, VIB-KU Leuven Center for Cancer Biology, Leuven, BelgiumLaboratory of Angiogenesis and Vascular Metabolism, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, BelgiumInstitute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-Universität, Munich, GermanyLung Immunity Translational Research Group in Respiratory Diseases, Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain0DZHK (German Center for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, GermanyInstitute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-Universität, Munich, Germany0DZHK (German Center for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany1Swiss Cardiovascular Center, Division of Angiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland2Department for BioMedical Research (DBMR) Bern University Hospital, University of Bern, Bern, Switzerlandhttps://www.frontiersin.org/articles/10.3389/fcell.2025.1559828/fullcardiovascular diseasemetabolisminflammationimmune systematherosclerosisomics |
| spellingShingle | Emiel P. C. van der Vorst Emiel P. C. van der Vorst Emiel P. C. van der Vorst Emiel P. C. van der Vorst Jeffrey Kroon Jeffrey Kroon Jeffrey Kroon Jeffrey Kroon Raquel Guillamat-Prats Raquel Guillamat-Prats Raquel Guillamat-Prats Yvonne Döring Yvonne Döring Yvonne Döring Yvonne Döring Editorial: Vascular- and immuno-metabolism as drivers of cardiovascular disease: insights obtained from omics approaches Frontiers in Cell and Developmental Biology cardiovascular disease metabolism inflammation immune system atherosclerosis omics |
| title | Editorial: Vascular- and immuno-metabolism as drivers of cardiovascular disease: insights obtained from omics approaches |
| title_full | Editorial: Vascular- and immuno-metabolism as drivers of cardiovascular disease: insights obtained from omics approaches |
| title_fullStr | Editorial: Vascular- and immuno-metabolism as drivers of cardiovascular disease: insights obtained from omics approaches |
| title_full_unstemmed | Editorial: Vascular- and immuno-metabolism as drivers of cardiovascular disease: insights obtained from omics approaches |
| title_short | Editorial: Vascular- and immuno-metabolism as drivers of cardiovascular disease: insights obtained from omics approaches |
| title_sort | editorial vascular and immuno metabolism as drivers of cardiovascular disease insights obtained from omics approaches |
| topic | cardiovascular disease metabolism inflammation immune system atherosclerosis omics |
| url | https://www.frontiersin.org/articles/10.3389/fcell.2025.1559828/full |
| work_keys_str_mv | AT emielpcvandervorst editorialvascularandimmunometabolismasdriversofcardiovasculardiseaseinsightsobtainedfromomicsapproaches AT emielpcvandervorst editorialvascularandimmunometabolismasdriversofcardiovasculardiseaseinsightsobtainedfromomicsapproaches AT emielpcvandervorst editorialvascularandimmunometabolismasdriversofcardiovasculardiseaseinsightsobtainedfromomicsapproaches AT emielpcvandervorst editorialvascularandimmunometabolismasdriversofcardiovasculardiseaseinsightsobtainedfromomicsapproaches AT jeffreykroon editorialvascularandimmunometabolismasdriversofcardiovasculardiseaseinsightsobtainedfromomicsapproaches AT jeffreykroon editorialvascularandimmunometabolismasdriversofcardiovasculardiseaseinsightsobtainedfromomicsapproaches AT jeffreykroon editorialvascularandimmunometabolismasdriversofcardiovasculardiseaseinsightsobtainedfromomicsapproaches AT jeffreykroon editorialvascularandimmunometabolismasdriversofcardiovasculardiseaseinsightsobtainedfromomicsapproaches AT raquelguillamatprats editorialvascularandimmunometabolismasdriversofcardiovasculardiseaseinsightsobtainedfromomicsapproaches AT raquelguillamatprats editorialvascularandimmunometabolismasdriversofcardiovasculardiseaseinsightsobtainedfromomicsapproaches AT raquelguillamatprats editorialvascularandimmunometabolismasdriversofcardiovasculardiseaseinsightsobtainedfromomicsapproaches AT yvonnedoring editorialvascularandimmunometabolismasdriversofcardiovasculardiseaseinsightsobtainedfromomicsapproaches AT yvonnedoring editorialvascularandimmunometabolismasdriversofcardiovasculardiseaseinsightsobtainedfromomicsapproaches AT yvonnedoring editorialvascularandimmunometabolismasdriversofcardiovasculardiseaseinsightsobtainedfromomicsapproaches AT yvonnedoring editorialvascularandimmunometabolismasdriversofcardiovasculardiseaseinsightsobtainedfromomicsapproaches |